SGHT Latest News, Press Relases and Analysis

All

Press Releases

19 days ago - By: Chartmill - Mentions: ACHV LBRT EQ RCEL ...

Top movers in Friday's session

19 days ago - By: Chartmill - Mentions: PLX ACHV LBRT STRO ...

Top stock movements in today's session.

16 hours ago - By: Sight Sciences, Inc.

Sight Sciences to Present at Two Upcoming Investor Conferences

13 days ago - By: Sight Sciences, Inc.

Sight Sciences to Report Third Quarter 2025 Financial Results on November 6, 2025

19 days ago - By: Benzinga - Mentions: XRTX ACHV GNPX KZR ...

12 Health Care Stocks Moving In Friday's Intraday Session

19 days ago - By: Chartmill - Mentions: PLX SLI KEP MB ...

Which stocks are gapping on Friday?

19 days ago - By: Sight Sciences, Inc.

Sight Sciences Announces Fee Schedule Establishment from Novitas Solutions and First Coast Service Options for the TearCare® Interventional Dry Eye Procedure

2 months ago - By: Sight Sciences, Inc.

Sight Sciences Announces Publication of a Systematic Literature Review and Meta-Analysis Showing OMNI® Surgical System Achieves Clinically Significant, Long-Term Reductions in IOP and Medication Use

2 months ago - By: Sight Sciences, Inc.

Sight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare’s® Expanded Coverage of Glaucoma Surgical Treatments

2 months ago - By: Sight Sciences, Inc.

Sight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO

2 months ago - By: Zacks Investment Research - Mentions: JNJ ALC GKOS

Glaukos Builds Dual Growth Engines Amid Market Headwinds

2 months ago - By: Sight Sciences, Inc.

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference

3 months ago - By: Benzinga

What 4 Analyst Ratings Have To Say About Sight Sciences

3 months ago - By: Zacks Investment Research

Compared to Estimates, Sight Sciences (SGHT) Q2 Earnings: A Look at Key Metrics

3 months ago - By: Zacks Investment Research - Mentions: DRIO

Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates

3 months ago - By: Zacks Investment Research - Mentions: VCYT

Veracyte (VCYT) Tops Q2 Earnings and Revenue Estimates

3 months ago - By: Sight Sciences, Inc.

Sight Sciences Announces the Results of a Cost-Utility Analysis Demonstrating Cost Savings and Greater Health Utility with the TearCare® System Compared to Cyclosporine 0.05% for Treating Meibomian Gland Disease-Associated Dry Eye Disease

3 months ago - By: Sight Sciences, Inc.

Sight Sciences Announces the Publication of the 24-Month Results of the SAHARA RCT Demonstrating the Durability of the TearCare® Procedure for the Treatment of Dry Eye Disease

3 months ago - By: Sight Sciences, Inc.

Sight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025

6 months ago - By: Zacks Investment Research

Sight Sciences (SGHT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

6 months ago - By: Zacks Investment Research - Mentions: CLPT

Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates

6 months ago - By: Sight Sciences, Inc.

Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance

6 months ago - By: Sight Sciences, Inc.

Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance

6 months ago - By: Zacks Investment Research - Mentions: AORT

Artivion (AORT) Lags Q1 Earnings Estimates

6 months ago - By: Sight Sciences, Inc.

Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025

7 months ago - By: Sight Sciences, Inc.

Sight Sciences Appoints Gary Burbach to its Board of Directors

7 months ago - By: Sight Sciences, Inc.

Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio

7 months ago - By: Sight Sciences, Inc.

Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th

8 months ago - By: Sight Sciences, Inc.

Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance

8 months ago - By: Sight Sciences, Inc.

Sight Sciences to Present Comprehensive Clinical Data on the OMNI® Surgical System at the 2025 American Glaucoma Society Annual Meeting

9 months ago - By: Sight Sciences, Inc.

SIGHT SCIENCES INC (SGHT) Stock News

SGHT Latest News, Press Relases and Analysis

Top movers in Friday's session

Top stock movements in today's session.

Sight Sciences to Present at Two Upcoming Investor Conferences

Sight Sciences to Report Third Quarter 2025 Financial Results on November 6, 2025

12 Health Care Stocks Moving In Friday's Intraday Session

Which stocks are gapping on Friday?

Sight Sciences Announces Fee Schedule Establishment from Novitas Solutions and First Coast Service Options for the TearCare® Interventional Dry Eye Procedure

Sight Sciences Announces Publication of a Systematic Literature Review and Meta-Analysis Showing OMNI® Surgical System Achieves Clinically Significant, Long-Term Reductions in IOP and Medication Use

Sight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare’s® Expanded Coverage of Glaucoma Surgical Treatments

Sight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO

Glaukos Builds Dual Growth Engines Amid Market Headwinds

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference

What 4 Analyst Ratings Have To Say About Sight Sciences

Compared to Estimates, Sight Sciences (SGHT) Q2 Earnings: A Look at Key Metrics

Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates

Veracyte (VCYT) Tops Q2 Earnings and Revenue Estimates

Sight Sciences Announces the Results of a Cost-Utility Analysis Demonstrating Cost Savings and Greater Health Utility with the TearCare® System Compared to Cyclosporine 0.05% for Treating Meibomian Gland Disease-Associated Dry Eye Disease

Sight Sciences Announces the Publication of the 24-Month Results of the SAHARA RCT Demonstrating the Durability of the TearCare® Procedure for the Treatment of Dry Eye Disease

Sight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025

Sight Sciences (SGHT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates

Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance

Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance

Artivion (AORT) Lags Q1 Earnings Estimates

Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025

Sight Sciences Appoints Gary Burbach to its Board of Directors

Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio

Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th

Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance

Sight Sciences to Present Comprehensive Clinical Data on the OMNI® Surgical System at the 2025 American Glaucoma Society Annual Meeting

Sight Sciences to Present at Citi’s 2025 Unplugged MedTech and Life Sciences Access Day